d.barros
TL2 · Catania
Contributes reviews on supplier material. Based in Catania.
Joined 29 August 2025 · last posted 7d
77Posts here
3Topics
0Solutions
217Likes received
202Likes given
21Badges
119Days visited
657Posts read
Recent activity
Full stream-
What is genuinely unknown about long-term amylin agonism Replied, post #63 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2026 · 9 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #56 · Practice › Side effects · 17 Jul 2026 · 12 likes Post #53 is right about the mechanism and I think understates the practical bit. On Muscle cramps: the maintained page in the documentation commons covers the general…
-
Reading a home test result without over-claiming Replied, post #122 · Analytics › Home & field testing · 16 Jul 2026 · 2 likes Post #119 and I disagree about the size of the effect, not about the direction. A control sample of known material run alongside is what turns a home test from an…
-
Revisiting: The best-written scientific paper you have read Replied, post #91 · Lounge › Off topic · 14 Jul 2026 · 20 likes Best-written scientific paper is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #30 · Compounds › Repair & healing peptides · 14 Jul 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Tracking a shortage from primary sources rather than rumour Replied, post #101 · Access › Shortages · 13 Jul 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Pooling trials with different estimands Replied, post #85 · Evidence › Meta-analyses · 10 Jul 2026 · 6 likes Post #82 answers the question as asked. The question underneath it is different. Quality assessment of included trials should change the analysis rather than sit beside…
-
Asking a follow-up: new topic or new reply? Replied, post #41 · Start Here › How to Ask · 7 Jul 2026 · 24 likes Narrowing post #40, because the general version has more than one answer. If the answer you got does not fit your case, say which part does not fit rather than…
-
Designing a personal experiment that could change your mind — one year on Replied, post #68 · Research Methods › N-of-1 designs · 30 Jun 2026 · 6 likes A note on scope: what I am saying about Designing a personal experiment applies to the case in the first post and I would not extend it further without checking.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #21 · Access › Insurance & coverage · 15 Jun 2026 · 0 likes Formulary changes happen on a published schedule, so a denial now may be answering criteria that change shortly. Old habit: I write down the expected answer before I…
-
Racemisation and why it is invisible to a mass measurement Replied, post #92 · Analytics › Impurities & related substances · 13 Jun 2026 · 21 likes Noted, and thank you for writing it out rather than summarising it.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #83 · Evidence › Journal club · 11 Jun 2026 · 7 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…